Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

No correlation between tumor markers and prognosis under polygenic control systems.

M Chigira1, T Shinozaki, T Shimizu

  • 1Department of Orthopedic Surgery, Gunma University School of Medicine, Japan.

Medical Hypotheses
|August 1, 1990
PubMed
Summary

Serum tumor markers do not predict malignant tumor prognosis due to independent genetic control. These markers may only indicate treatment response if their expression is not time-dependent.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prognostic significance of vascular invasion by endometrial carcinoma.

Cancer·1996
Same author

A water-soluble antitumor glycoprotein from Chlorella vulgaris.

Planta medica·1996
Same author

Fate of erythritol after single oral administration to rats and dogs.

Regulatory toxicology and pharmacology : RTP·1996
Same author

Generation of human monoclonal antibodies recognising membranous antigens of the lung adenocarcinoma cell line A549 using an AMeX immunohistostaining method.

British journal of cancer·1996
Same author

Interaction between enoxacin, a new antimicrobial, and nimesulide, a new non-steroidal anti-inflammatory agent in mice.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·1996
Same author

Fluorescent estimation of H2O2-induced changes in cell viability and cellular nonprotein thiol level of dissociated rat thymocytes.

Japanese journal of pharmacology·1996

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Serum tumor markers indicate the presence of malignant tumors.
  • Prognosis in cancer patients is influenced by multiple factors, including metastasis, growth rate, drug sensitivity, and host response.
  • These prognostic factors exhibit significant inter-patient variability.

Purpose of the Study:

  • To evaluate the correlation between serum tumor markers and the prognosis of patients with malignant tumors.
  • To determine the conditions under which tumor markers can effectively demonstrate treatment response.

Main Methods:

  • Analysis of the independent genetic control of tumor marker levels and patient prognosis.
  • Review of various prognostic factors influencing cancer patient outcomes.

Related Experiment Videos

  • Examination of the time-dependent expression patterns of tumor markers in relation to treatment.

    • Main Results:

    • Serum tumor marker levels are not correlated with the prognosis of malignant tumors.
    • Tumor marker levels and prognosis are independently regulated by polygenic factors.
    • Tumor markers can only demonstrate treatment response if their expression remains stable over time.

    Conclusions:

    • Serum tumor markers should not be used to predict malignant tumor prognosis.
    • Prognostic factors are complex and vary significantly among individuals.
    • The utility of tumor markers for assessing treatment efficacy is limited to specific, time-independent expression scenarios.